SCHEMBL18707644

SCHEMBL18707644

Cc1ccc(-c2onc(-c3ccc(Cl)cc3F)c2C(O)c2cccnc2)c(F)c1

nearest known ligand 0.37

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ATM Q13315 1/20 0.37
CYP3A4 P08684 7/20 0.36
PDE10A Q9Y233 1/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
LMNA P02545 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
BRD4 O60885 1/20 0.36
CYP3A5 P20815 6/20 0.35
GAA P10253 1/20 0.35
KCNA5 P22460 2/20 0.35
GABRA5 P31644 1/20 0.35
BCHE P06276 1/20 0.34
KCND3 Q9UK17 1/20 0.34
MME P08473 1/20 0.34
AKR1C3 P42330 1/20 0.33
AKR1C2 P52895 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12211716 1.00 ATM (0.37) ATMCYP3A4PDE10ASMN1; SMN2LMNA
SCHEMBL29367523 0.90 ATM (0.39) ATMCYP3A4PDE10ASMN1; SMN2LMNA
SCHEMBL3114118 0.90 ATM (0.39) ATMCYP3A4PDE10ASMN1; SMN2LMNA
SCHEMBL3124272 0.90 ATM (0.39) ATMCYP3A4PDE10ASMN1; SMN2LMNA
SCHEMBL2471057 0.90 ATM (0.39) ATMCYP3A4PDE10ASMN1; SMN2LMNA
SCHEMBL29369392 0.90 ATM (0.39) ATMCYP3A4PDE10ASMN1; SMN2LMNA
SCHEMBL2444825 0.90 ATM (0.39) ATMCYP3A4PDE10ASMN1; SMN2LMNA
SCHEMBL29360928 0.90 ATM (0.39) ATMCYP3A4PDE10ASMN1; SMN2LMNA
SCHEMBL2444831 0.90 ATM (0.39) ATMCYP3A4PDE10ASMN1; SMN2LMNA
SCHEMBL12211648 0.87 CYP3A4 (0.42) CYP3A4SMN1; SMN2CYP3A5KCNA5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170094971-A1 PLANT DISEASE CONTROL COMPOSITION AND METHOD FOR CONTROLLING PLANT DISEASE BY APPLICATION OF SAME MITSUI CHEMICALS AGRO, INC. (JP) 2017-04-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170094971-A1 PLANT DISEASE CONTROL COMPOSITION AND METHOD FOR CONTROLLING PLANT DISEASE BY APPLICATION OF SAME BROX, HAX1, CHRM1 ATM 3009/4885CYP3A4 1451/4885PDE10A 1612/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.